Dronabinol

屈大麻酚

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameDronabinol
Drug Alias NameDronabinolum卓那比诺四氢大麻酚DELTA9-TetrahydrocannabinolElevat +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor agonists
TargetsCannabinoid receptor
Therapy Area/IndicationsBone metastasesChemotherapy-induced nausea and vomitingAgitation +[58] 
Global Approved IndicationsAnorexia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1985/05/31
Country/TerritoryCanadaUnited StatesNetherlands +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health And Science UniversityUniversity Of Southern DenmarkYale University +[25] 
Inactive CompaniesCanadian Institutes Of Health Research (Cihr)Radboud University Medical CenterThe Brigham and Women's Hospital +[22] 
Active IndicationsAgitationStress Disorders, Post-TraumaticSchizophrenia +[31] 
Inactive IndicationsBone metastasesChemotherapy-induced nausea and vomitingBipolar Disorder +[27] 

Other Information

ATC CodeA04AD10
Related LinksWikipediaDrugBankKEGG